Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 8,691 | 10,782 | 9,760 | 12,024 | 10,599 |
| Cost of Goods | 2,278 | 3,123 | 2,463 | 2,710 | 2,751 |
| Gross Profit | 6,414 | 7,660 | 7,298 | 9,314 | 7,847 |
| Operating Expenses | 14,483 | 17,344 | 13,166 | 14,949 | 11,451 |
| Operating Income | -7,791 | -9,562 | -5,406 | -4,925 | -2,852 |
| Other Income | -1,175 | -481 | -1,000 | 247 | -1,316 |
| Pre-tax Income | -8,966 | -10,043 | -6,406 | -4,678 | -4,168 |
| Net Income Continuous | -8,966 | -9,307 | -6,406 | -4,678 | -4,168 |
| Net Income | $-8,966 | $-9,307 | $-6,406 | $-4,678 | $-4,168 |
| EPS Basic Total Ops | -0.21 | -0.21 | -0.15 | -0.11 | -0.10 |
| EPS Basic Continuous Ops | -0.21 | -0.21 | -0.15 | -0.11 | -0.10 |
| EPS Diluted Total Ops | -0.21 | -0.21 | -0.15 | -0.11 | -0.10 |
| EPS Diluted Continuous Ops | -0.21 | -0.21 | -0.15 | -0.11 | -0.10 |
| EBITDA(a) | $-7,509 | $-8,949 | $-5,169 | $-4,801 | $-2,696 |